Philippe Amouyal

Insider Reports History

Location
Washington, DC
Signature
/s/ Kenneth Robert Bertram, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Philippe Amouyal:

Company Role Class Num Shares Value Price $ Report Date Ownership
CAVA GROUP, INC. Director Common Stock 18,074 $1,801,977 $99.70 20 Jun 2025 Direct
LEXICON PHARMACEUTICALS, INC. Director Common Stock 285,174 $145,438 $0.5100 13 May 2025 Direct
LEXICON PHARMACEUTICALS, INC. Director Restricted Stock Units 89,312 $96,442 $2.62 03 Jun 2025 Direct
LEXICON PHARMACEUTICALS, INC. Director Stock Option (Right to Buy) 103,806 03 Jun 2025 Direct

Insider Reports Filed by Philippe Amouyal

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CAVA CAVA GROUP, INC. 20 Jun 2025 1 $0 4 Director 24 Jun 2025, 17:23
LXRX LEXICON PHARMACEUTICALS, INC. 03 Jun 2025 2 $0 4 Director 03 Jun 2025, 16:21
LXRX LEXICON PHARMACEUTICALS, INC. 13 May 2025 2 $0 4 Director 13 May 2025, 17:49
CAVA CAVA GROUP, INC. 20 Jun 2024 1 $0 4 Director 24 Jun 2024, 16:05
LXRX LEXICON PHARMACEUTICALS, INC. 13 May 2024 2 $0 4 Director 13 May 2024, 16:00
LXRX LEXICON PHARMACEUTICALS, INC. 28 Apr 2024 2 $0 4 Director 29 Apr 2024, 16:16
CAVA CAVA GROUP, INC. 17 Nov 2023 1 +$331,800 4 Director 21 Nov 2023, 16:00
LXRX LEXICON PHARMACEUTICALS, INC. 13 Nov 2023 1 +$201,520 4 Director 14 Nov 2023, 16:12
CAVA CAVA GROUP, INC. 20 Jun 2023 1 $0 4 Director 22 Jun 2023, 16:36
CAVA CAVA GROUP, INC. 15 Jun 2023 0 $0 3 Director 15 Jun 2023, 16:37
LXRX LEXICON PHARMACEUTICALS, INC. 21 May 2023 2 $0 4 Director 22 May 2023, 16:01
LXRX LEXICON PHARMACEUTICALS, INC. 28 Apr 2023 2 $0 4 Director 28 Apr 2023, 16:21
LXRX LEXICON PHARMACEUTICALS, INC. 21 May 2022 2 $0 4 Director 23 May 2022, 16:12
LXRX LEXICON PHARMACEUTICALS, INC. 30 Apr 2022 2 $0 4 Director 02 May 2022, 16:11